| Literature DB >> 35335100 |
Alexandra Mureşan1, Cosmin Mureşan2, Madalina Siteavu3,4, Electra Avram3, Diana Bochynska5, Marian Taulescu3,5.
Abstract
Equine herpesviruses are important pathogens causing significant economic loss in equine and asinine populations. EHV-1/4 strains are mainly associated with respiratory distress. The aim of this study is to report the first EHV 4-associated respiratory disease in donkeys in Romania. Thirty-seven of three hundred jennies in an ecological donkey farm in southwest Romania started initially showing signs of severe upper respiratory tract disease, with ten concomitant late abortions/neonatal deaths and three neurological cases. There were nine fatalities. Pathological examination was performed, and samples were collected for Real-Time PCR analysis and histology. In addition, serum samples from 28 individuals with respiratory symptoms were collected and tested using indirect ELISA. RT-PCR identified the EHV-4 strain. Acute, diffuse necrotizing bronchointerstitial pneumonia with occasional intraepithelial intranuclear viral inclusion bodies was identified. Additionally, EHV-1/4-specific antibodies were found in 15 of the 28 sampled animals. Few studies on donkeys and herpesviruses have been published, and this is the first reported case of EHV-4 outbreak in Romania. There is a need for more extensive seroprevalence studies as, currently, the status of EHV-4 infection in donkeys in Romania is unknown.Entities:
Keywords: EHV-4; donkey; equine herpesvirus; outbreak; serology
Year: 2022 PMID: 35335100 PMCID: PMC8953855 DOI: 10.3390/vaccines10030468
Source DB: PubMed Journal: Vaccines (Basel) ISSN: 2076-393X
Overview of symptoms and ELISA (S/P cutoff 0.3) results.
| Mean Age, Age Ranges | URT Symptoms | Pyrexia | Abortion | EHV Positive Based on | EHV Negative Based on |
|---|---|---|---|---|---|
| 4.2 years (3–6 years) | 28/28 | 28/28 | 3/28 | 15/28 | 13/28 |
Figure 1Pathological findings of herpesviral bronchointerstitial pneumonia in a donkey. (A) The pleural cavity showing a moderate amount of clear fluid (arrow); (B) the lungs failed to collapse after opening the thorax and showed a diffuse rubbery–firm texture with prominent rib imprints, and subpleural and interstitial edema with lymphangiectasia (demarcated area and higher magnification in the inset); (C) severe congestion, subpleural and interstitial edema with lymphangiectasia. HE stain, Bar = 50 μm; (D) necrotizing and neutrophilic bronchiolitis (arrow). HE stain, Bar = 50 μm; (E) epithelial syncytial cells (arrow). HE stain, Bar = 20 μm; (F) intranuclear viral inclusion bodies (Cowdry A type) in the bronchiolar epithelium (arrow). HE stain, Bar = 20 μm; inset showing the intranuclear inclusion body at higher magnification. HE stain.
Figure 2S/P ratios of 0.3 and above were considered cut-off values for positive samples. Fifteen out of twenty-eight serum samples were positive.
Overview of reports documenting seroprevalence of EHV-1 and EHV-4 in donkeys, 2008 to present.
| Report | EHV Type, Symptomatology | Percentage of Positives | Country, Year | Reference |
|---|---|---|---|---|
| 1 | EHV-1 | 6.6% (1/15) | Brazil, 2008 | [ |
| 2 | EHV-1, both symptomatic and asymptomatic | 24.2% (31/128) | Turkey, 2009 | [ |
| 3 | EHV-1 and 4, asymptomatic | 0% (0/4) | Brazil, 2010 | [ |
| 4 | EHV-4, asymptomatic | 69.7% (134/192) | Bulgaria, 2011 | [ |
| 5 | EHV-1 | 20.2% (21/104) | Ethiopia, 2014 | [ |
| 6 | EHV-1, asymptomatic | 33.3% (4/12) | Tanzania, Namibia, 2015 | [ |
| 7 | EHV-1, symptomatic | 14.28% (2/14) | EUA, 2016 | [ |
| 8 | EHV-1 | 51.85% (126/243) | Turkey, 2015 | [ |
| 9 | EHV-1 and/or 4, asymptomatic | 69.5% (57/82) | Sudan, 2016 | [ |
| 10 | EHV-4, asymptomatic | 14.8% (16/108) | Iran, 2016 | [ |
| 11 | EHV-1, symptomatic | 98.79% (82/83) | Ethiopia, 2017 | [ |
| 12 | EHV-1 and/or 4 | 74.7% (201/269) | Ethiopia, 2017 | [ |
| 13 | EHV-1, symptomatic | 19.5% (8/41) | Ethiopia, 2017 | [ |
| 14 | EHV-1 | 10% (4/40) | West Indies, 2017 | [ |
| 15 | EHV-1 and/or 4, asymptomatic | 47% (40/85) | Brazil, 2017 | [ |
| 16 | EHV-1 | 50% (8/16) | Egypt, 2019 | [ |
| 17 | EHV-1, symptomatic | 76% (19/25) | Ethiopia, 2021 | [ |